Stay updated with breaking news from Anaptysbio daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $46.22 Consensus Price Target from Analysts wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs reissued their outperform rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report released on Tuesday morning, Zacks.com reports. Leerink Partnrs also issued estimates for AnaptysBio’s Q1 2024 earnings at ($1.41) EPS, Q2 2024 earnings at ($1.44) EPS, Q3 2024 earnings at ($1.45) EPS, Q4 2024 earnings at ($1.42) EPS, […] ....
SG Americas Securities LLC bought a new position in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,875 shares of the biotechnology company’s stock, valued at approximately $126,000. Other large investors also recently modified their […] ....